Global /India /Healthcare /Drug Manufacturers - General /531739
chevron_leftBack
Gennex Laboratories Ltd. logo

Gennex Laboratories Ltd.

531739
BSE: 531739 Delayed
10.11INR -2%
0.1071 USD
As of 20 June 2026, Gennex Laboratories Ltd. has a market cap of $26.02M USD, ranking #35251 globally and #2439 in India. It ranks #3186 in the Healthcare sector, and #1076 in the Drug Manufacturers - General industry.
Global Rank
35251
Country Rank
2439
Sector Rank
3186
Industry Rank
1076
Key Stats
Market Cap
$26.02MUSD
2.46B INR
Enterprise Value
$31.23MUSD
2.95B INR
Revenue (TTM)
$16.12MUSD
1.52B INR
EBITDA (TTM)
$1.97MUSD
185.63M INR
Net Income (TTM)
$2.03MUSD
191.43M INR
EBITDA Margin
12%
Profit Margin
13%
PE Ratio
13.5
PS Ratio
1.6
PB Ratio
1.1
EV/EBITDA
15.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Arihant Baid open_in_new
Employees
115
Founded
1985
Website
gennexlab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2% -1.6% 29% -16% -39% -21%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
531739 (GENNEX)
Gennex Laboratories Ltd
ISIN: INE509C01026
Shares Out.:
227.448M1
TV:
SA:
YF:
GF:
BA:
MS:
10.11 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Gennex Laboratories Ltd.

Gennex Laboratories Limited manufactures and sells bulk drugs, intermediates, and biotech products. The company offers Guaifenesin, an expectorant used as a mucolyte; Methocarbamol for skeletal muscle relaxant; Fexofenadine Hcl for treating antihistamines; Phenazopyridine Hcl for the treatment of urinary tract analgesic; Fluconazole for antifungals; Melitracen Hcl for treating tricyclic antidepressant; Sertraline Hcl, a selective serotonin reuptake inhibitor; Chlorphenesin and Mephenesin for muscle relaxant; and Allopurinol, a xanthine oxidase inhibitor. It has operations in India, Algeria, Bangladesh, Barzil, Bolivia, Colombia, the Czech Republic, Egypt, El Salvador, Germany, Guatemala City, Mexico, Peru, Spain, Turkey, Thailand, the United Arab Emirates, and Vietnam. Gennex Laboratories Limited was formerly known as Prudential Pharmaceuticals Limited and changed its name to Gennex Laboratories Limited in September 2007. Gennex Laboratories Limited was incorporated in 1985 and is based in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
174K%
39.1
DIVISLAB
$18.38B
1.73T INR
71K%
70.0
$15.17B
1.43T INR
58K%
63.0
$11.73B
1.11T INR
45K%
19.6
MANKIND
$9.87B
931.67B INR
38K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
37K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
3M%
38.1
JNJ
$547.28B
2M%
26.4
ABBV
$360.63B
1M%
97.4
$318.3B
256.25B CHF
1M%
19.9
AZN
$284.64B
215.59B GBP
1M%
27.6
MRK
$274.03B
1M%
15.1
chevron_leftBack